Humana Inc. (HUM)
Here's Why Investors Should Retain Humana Stock for Now
HUM benefits from Medicare Advantage growth, CenterWell expansion and strong cash generation, but rising costs and debt remain concerns.
Can Humana's Star Ratings Rebound Unlock MA Earnings Power?
HUM's Star Ratings recovery is set to show early progress, but October's CMS release will test its MA turnaround and path to a 2028 margin target.
Can Humana Improve Caregiver Retention With HealthStream Deal?
HUM's HealthStream deal backs 1,000 caregiver scholarships and new tools to improve recruitment and retention in Indiana.
Humana Q2 Earnings Call Highlights
Humana NYSE: HUM said its 2026 performance is tracking in line with expectations, with management emphasizing planned Medicare Advantage margin expansion in 2027, progress in its Stars program and continued operating-cost reductions as key components of its path toward a sustainable pretax margin of at least 3% in 2028.
Humana Q2 Earnings Review: Management Tight-Lipped, But Recovery Still On Track
Humana Inc. targets a sustainable 3% pre-tax margin by 2028, focusing on Medicare Advantage plan quality and operational efficiency. Despite robust revenue growth, HUM's profit margins have sharply declined, with Q2 2026 pre-tax margin at 1.8%, down from 6.7% in 2020. Management remains committed to margin recovery via improved Stars ratings, cost reductions, and selective plan exits, aiming for top-quartile performance.
Humana Q2 Earnings Beat Estimates on Medical Membership Growth
HUM's Q2 earnings top estimates as medical membership growth, premium gains and CenterWell strength lift results despite higher costs.
Compared to Estimates, Humana (HUM) Q2 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Humana (HUM) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Humana (HUM) Q2 Earnings and Revenues Top Estimates
Humana (HUM) came out with quarterly earnings of $7.61 per share, beating the Zacks Consensus Estimate of $6.22 per share. This compares to earnings of $6.27 per share a year ago.
Humana Profits Hit $694 Million As Medicare Costs Fall In Line
Humana reported second quarter net income of $694 million as costs of care for older adults in its Medicare Advantage plans fell in line with company expectations.
Humana Cuts Outlook Again on Lower Medicare Ratings
Humana cut its earnings outlook for the year, as the company continues to face earnings headwinds from lower Medicare Advantage Star Ratings for 2026.
Gear Up for Humana (HUM) Q2 Earnings: Wall Street Estimates for Key Metrics
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Humana (HUM), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2026.
Can Humana Beat Q2 Earnings Estimates on Growing Premiums?
HUM enters Q2 earnings with strong premium and membership growth expectations, but rising medical costs and expenses could test its bottom line.
